Telomerase Reverse Transcriptase: Difference between revisions
David Canner (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| (7 intermediate revisions by 3 users not shown) | |||
| Line 17: | Line 17: | ||
== '''Experimental fragment with TEN''' == | == '''Experimental fragment with TEN''' == | ||
<applet load='2b2a' size='400' frame='true' align='right' caption=' | <applet load='2b2a' size='400' frame='true' align='right' caption='Tetrahymena thermophila telomerase reverse transcriptase TEN domain [[2b2a]]' scene='Sandbox/Presentation/3' /> | ||
A Tetrahymena Thermophila TERT fragment consisting of residues 2-191 with an N-terminal His6 tag was cristallized in space group P3 with <scene name='Sandbox/Three/1'>three</scene> TERT molecules present in the crystallographic asymmetric unit. | A Tetrahymena Thermophila TERT fragment consisting of residues 2-191 with an N-terminal His6 tag was cristallized in space group P3 with <scene name='Sandbox/Three/1'>three</scene> TERT molecules present in the crystallographic asymmetric unit. | ||
This 23.5-kDa fragment contains only one methionine residue, making phasing by substitution with selenomethionine (SeMet) difficult. | This 23.5-kDa fragment contains only one methionine residue, making phasing by substitution with selenomethionine (SeMet) difficult. | ||
| Line 67: | Line 67: | ||
Because the TEN domain is essential for telomerase activity and its structure seems to be conserved trough evolution, this portion of TERT is a potential new target for antitelomerase compounds. | Because the TEN domain is essential for telomerase activity and its structure seems to be conserved trough evolution, this portion of TERT is a potential new target for antitelomerase compounds. | ||
==Additional Resources== | ==3D structures of telomerase reverse transcriptase== | ||
See [[Telomerase]] | |||
=='''Additional Resources'''== | |||
For additional information, See: [[Cancer]] | For additional information, See: [[Cancer]] | ||
<br /> | <br /> | ||
| Line 78: | Line 82: | ||
This page was created with content from a page authored by [[User:Tanja Emmerich]] and [[User:Vinzenz Alejandro Bayro Kaiser]]. | This page was created with content from a page authored by [[User:Tanja Emmerich]] and [[User:Vinzenz Alejandro Bayro Kaiser]]. | ||
[[Category:Topic Page]] | |||